ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

RNAC Cartesian Therapeutics Inc

27.29
-2.00 (-6.83%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Cartesian Therapeutics Financial Summary

The current RNAC market cap is 4.42B. The company's latest EPS is USD -1.3567 and P/E is -20.09.

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 5.94M5.25M6.55M8.27M5.84M
Operating Income -18.38M-18.64M-13.07M-36.33M-13.35M
Net Income -21.66M-11.39M-9M-177.66M-56.82M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 6.68M16.6M85.08M110.78M26M
Operating Income -52.46M-56.82M-4.6M14.54M-86.42M
Net Income -55.35M-68.88M-25.69M35.38M-219.71M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 155.69M139.51M106.03M305.05M325.21M
Total Liabilities 81.11M74.06M45.71M444.68M442.01M
Total Equity 74.58M65.45M60.33M-440.18M-116.8M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 99.57M165.44M159.88M165.89M305.05M
Total Liabilities 91.17M183.44M137.36M72.06M444.68M
Total Equity 8.4M-18.01M22.52M93.83M-440.18M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -8.77M-18.66M-27.88M-51.16M-15.92M
Investing 28.12M28.11M28.11M34.61M-602k
Financing 149k-2.44M-27.23M-13.15M43.03M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -51.44M34.88M-60.38M-31.63M-51.16M
Investing 229k-741k-17.14M-15M34.61M
Financing 105.04M14.43M52.9M39.22M-13.15M
Market Cap 4.42B
Price to Earnings Ratio -20.09
Price to Sales Ratio 169.74
Price to Cash Ratio 57.4
Price to Book Ratio -31.62
Dividend Yield -

Share Statistics

Shares Outstanding 161.95M
Average Volume (1 week) 71.8k
Average Volume (1 Month) 86.22k
52 Week Change 12.79%
52 Week High 42.60
52 Week Low 11.665
Spread (Intraday) 18.27 (42.58%)

Company Info

Company Name Cartesian Therapeutics Inc
Address corporation trust center
wilmington, delaware 19801
Website https://www.selectabio.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock